Clinical Trials Logo

Contraception clinical trials

View clinical trials related to Contraception.

Filter by:

NCT ID: NCT04339049 Completed - Contraception Clinical Trials

Comparative Efficacy of Lidocaine Spray Versus Vaginal Misoprostol in IUD Insertion

Start date: May 1, 2020
Phase: Phase 3
Study type: Interventional

the aim of the present study is to compare the safety and efficacy of lidocaine spray versus misoprostol in reducing pain during IUD insertion in adolescents and nulliparous women

NCT ID: NCT04336865 Not yet recruiting - Contraception Clinical Trials

Effect of Hormonal Contraception on Lower Urinary Tract Symptoms& Sexual Function

Start date: April 15, 2020
Phase:
Study type: Observational

Effect of hormonal contraception on lower urinary tract symptoms& sexual function

NCT ID: NCT04312061 Not yet recruiting - Contraception Clinical Trials

Effect of Oral Tramadol Administration Prior to IUD Insertion

Start date: March 30, 2020
Phase: Phase 3
Study type: Interventional

the aim of the study is to evaluate the safety and efficacy of oral tramadol administration in reducing pain during LNG- IUD insertion in adolescents and young women

NCT ID: NCT04311658 Not yet recruiting - Contraception Clinical Trials

Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion

Start date: March 30, 2020
Phase: Phase 3
Study type: Interventional

the aim of the study is to evaluate the safety and efficacy of isosorbide mononitrate vaginal administration in reducing pain during LNG-IUD insertion in adolescents and young women

NCT ID: NCT04306029 Completed - Contraception Clinical Trials

Improving Adherence to Postpartum Family Planning Guidance in Ghana

Start date: February 24, 2020
Phase: N/A
Study type: Interventional

Evaluating a Postpartum Family Planning Package (PPFP) in a Hybrid Type II implementation study with a stepped-wedge design.

NCT ID: NCT04291040 Active, not recruiting - Contraception Clinical Trials

Use of an Educational Multimedia Tool Versus Routine Care for the Uptake of Postpartum LARC in High-Risk Pregnancies

SUSTAIN
Start date: July 9, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate if the implementation of a multimedia based educational tool and regular reminders with shared decision-making will increase the rate of LARC uptake and retention in high risk pregnancy patients within 12 weeks of delivery and to study the rates of retention of LARC at 12 and 24 months and short-interval pregnancy rates.

NCT ID: NCT04291001 Active, not recruiting - Contraception Clinical Trials

Ovarian Function With ENG Implant and UPA Use

Start date: September 4, 2020
Phase: Early Phase 1
Study type: Interventional

Same day initiation of the etonogestrel (ENG) implant and oral ulipristal acetate (UPA) would overcome contraceptive access barriers to women with recent unprotected intercourse to ongoing contraception. Current clinical guidelines recommend delaying implant initiation for at least 1 week following UPA, as well as waiting 7 days before relying on the implant for contraception after initiation alone. This pilot will assess the effects of the implant alone and the implant inserted with same-day as UPA usage on ovarian activity. A total of 40 women desiring the implant, who are not at risk for pregnancy during the study timeline, will be recruited. Participants will be randomized to implant alone or same-day implant + oral UPA. Participants will have daily ultrasounds and blood draws to assess timing of ovulation for 1 week and then an exit visit at 14 days after randomization. The primary outcome is the incidence of ovulation in the 2 randomized treatment groups. Participants may continue the implant after the study per FDA guidelines and rely on it for contraception after the study is completed.

NCT ID: NCT04290390 Completed - Contraception Clinical Trials

Annovera™ Drug-Drug Interaction Study

Start date: February 12, 2020
Phase: Phase 1
Study type: Interventional

A Drug-Drug Interaction (DDI) study to evaluate the effects of itraconazole and rifampin on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol from the Annovera Contraceptive Vaginal System (CVS)

NCT ID: NCT04273594 Active, not recruiting - Contraception Clinical Trials

FemBloc® Permanent Contraception - Confirmation Feasibility Trial

BLOC
Start date: February 27, 2020
Phase: N/A
Study type: Interventional

The trial objectives include evaluating the adequacy of proposed mitigations for the previous pivotal trial of the FemBloc Permanent Contraceptive System and validating the confirmation procedure by comparing FemChec (ultrasound) to fluoroscopic hysterosalpingogram (fluoro HSG) for post-occlusion in the same patient.

NCT ID: NCT04272008 Completed - Contraception Clinical Trials

The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol

Start date: March 6, 2020
Phase: Phase 1
Study type: Interventional

This study will evaluate the effect of Annovera and tampon co-usage on the pharmacokinetics (PK) of segesterone acetate (SA) and ethinyl estradiol (EE).